CellSeed Inc. (TYO:7776)
Japan · Delayed Price · Currency is JPY 287.00
-8.00 (-2.71%)
At close: Feb 6, 2026
CellSeed Market Cap
CellSeed has a market cap or net worth of 10.21 billion as of February 6, 2026. Its market cap has decreased by -26.04% in one year.
Market Cap
10.21B
Enterprise Value
n/a
Revenue
161.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
287.00
Market Cap Chart
Since March 16, 2010, CellSeed's market cap has increased from 5.26B to 10.21B, an increase of 93.89%. That is a compound annual growth rate of 4.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 10.49B | 16.83% |
| Dec 30, 2025 | 8.98B | -35.09% |
| Dec 30, 2024 | 13.83B | 62.71% |
| Dec 29, 2023 | 8.50B | 107.22% |
| Dec 30, 2022 | 4.10B | 25.55% |
| Dec 30, 2021 | 3.27B | -13.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuno-Biological Laboratories | 14.11B |
| Kubota Pharmaceutical Holdings | 12.69B |
| Kidswell Bio | 12.05B |
| Stella Pharma | 11.33B |
| Nano Holdings | 10.47B |
| StemCell Institute | 8.53B |
| BrightPath Biotherapeutics | 8.02B |
| CellSource | 7.97B |